Literature DB >> 10457165

An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.

P Whiteaker1, A R Davies, M J Marks, I S Blagbrough, B V Potter, A J Wolstenholme, A C Collins, S Wonnacott.   

Abstract

[3H]-Methyllycaconitine ([3H]-MLA) is a new radioligand with selectivity for alpha7-type neuronal nicotinic acetylcholine receptors (nAChRs). In our previous study [Davies, A.R.L., Hardick, D.J., Blagbrough, I.S., Potter, B.V.L., Wolstenholme, A.J. & Wonnacott, S. (1999) Neuropharmacology, 38, 679-690], this radioligand labelled a single class of site in rat brain membranes; its pharmacology and distribution in crudely dissected brain regions closely paralleled that of the well-established alpha7-ligand [125I]-alpha-bungarotoxin. However, a small population of [3H]-MLA binding sites was apparently insensitive to alpha-bungarotoxin. Here we have extended the study to mouse brain, using autoradiography to examine the distribution of [3H]-MLA and [125I]-alpha-bungarotoxin binding sites. [3H]-MLA labelled a single class of site in mouse brain membranes with a KD of 2.2 nM and a Bmax of 45.6 fmol/mg protein. Specific binding, defined by unlabelled MLA (Ki = 0.69 nM), was completely inhibited by (-)-nicotine (Ki = 1.62 microM), whereas alpha-bungarotoxin inhibited only 85% of specific binding (Ki = 3.5 nM). The distributions of [125I]-alpha-bungarotoxin and [3H]-MLA binding sites were compared by autoradiography, and binding was quantitated in 72 brain regions. Binding of both radioligands was highly correlated, with highest densities in the dorsal tegmental nucleus of the pons, colliculi and hippocampus. Serial sections labelled with [3H]-MLA in the absence or presence of unlabelled MLA or alpha-bungarotoxin provided no evidence for any alpha-bungarotoxin-resistant binding. The results are discussed in terms of binding sites that are inaccessible to alpha-bungarotoxin in membrane preparations. This study demonstrates the utility of [3H]-MLA for characterization of alpha7-type nicotinic receptors in mammalian brain, and suggests that it labels a population identical to that defined by [125I]-alpha-bungarotoxin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457165     DOI: 10.1046/j.1460-9568.1999.00685.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  37 in total

1.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

2.  Nicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning.

Authors:  Justin W Kenney; Jonathan D Raybuck; Thomas J Gould
Journal:  Hippocampus       Date:  2012-01-23       Impact factor: 3.899

Review 3.  Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine.

Authors:  Justin W Kenney; Thomas J Gould
Journal:  Mol Neurobiol       Date:  2008-08-09       Impact factor: 5.590

4.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

5.  High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.

Authors:  Joshua W Gatson; James W Simpkins; Victor V Uteshev
Journal:  Brain Res Bull       Date:  2015-01-31       Impact factor: 4.077

6.  Regional metabolite levels and turnover in the awake rat brain under the influence of nicotine.

Authors:  Jie Wang; Lihong Jiang; Yifeng Jiang; Xiaoxian Ma; Golam M I Chowdhury; Graeme F Mason
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

7.  Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.

Authors:  Andrew G Horti; Hayden T Ravert; Yongjun Gao; Daniel P Holt; William H Bunnelle; Michael R Schrimpf; Tao Li; Jianguo Ji; Heather Valentine; Ursula Scheffel; Hiroto Kuwabara; Dean F Wong; Robert F Dannals
Journal:  Nucl Med Biol       Date:  2013-01-05       Impact factor: 2.408

8.  Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins.

Authors:  Matthew J Mulcahy; Joao A Paulo; Edward Hawrot
Journal:  J Proteome Res       Date:  2018-10-04       Impact factor: 4.466

9.  In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.

Authors:  Jun Toyohara; Kiichi Ishiwata; Muneyuki Sakata; Jin Wu; Shingo Nishiyama; Hideo Tsukada; Kenji Hashimoto
Journal:  PLoS One       Date:  2010-02-01       Impact factor: 3.240

10.  A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Authors:  Bopanna I Kalappa; Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.